Meticulous Research®—a leading global market research company, has recently published a comprehensive research report titled, ‘North America NGS Automation Market by Product {Workstations, Consumables}, Sequencing Type {Whole Genome, Exome, Targeted Genome}, Application {Drug Discovery, Diagnostics, Oncology}, End User {Hospitals, Pharmaceutical, Diagnostic Labs} - Forecast to 2030.’ This in-depth study provides a detailed analysis of the market’s current landscape, projected growth, and the key drivers shaping its trajectory.

Download Sample Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5736

According to the latest publication from Meticulous Research®, the North America NGS automation market is poised to achieve significant growth, registering a compound annual growth rate (CAGR) of 14% from 2024 to reach a market value of $776.1 million by 2030. This remarkable growth is attributed to several factors, including the increasing prevalence of cancer cases, the rising demand for NGS automation in laboratories, growing needs for optimized and streamlined workflows, and heightened investments in pharmaceutical research and development (R&D) alongside increasing healthcare expenditures. Moreover, the expanding applications of NGS technology and collaborations among industry vendors to develop library preparation protocols are expected to present lucrative opportunities for market expansion. However, the high cost of automation workstations could act as a constraint, moderating the market's growth potential.

Key Players Shaping the Market Landscape

The North America NGS automation market features a competitive landscape with several prominent players driving innovation and market expansion. Key companies operating in this space include:

• Agilent Technologies, Inc. (U.S.)
• Danaher Corporation (U.S.)
• Eppendorf AG (Germany)
• Hamilton Company (U.S.)
• PerkinElmer, Inc. (U.S.)
• Tecan Group Ltd. (Switzerland)
• BRAND GMBH + CO KG (Germany)
• Hudson Robotics (U.S.)
• SPT Labtech (U.K.)
• Thermo Fisher Scientific Inc. (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)

These companies are at the forefront of developing advanced NGS automation solutions, addressing critical industry challenges, and meeting evolving customer needs.

Market Segmentation and Future Outlook

The North America NGS automation market is comprehensively segmented by product, sequencing type, application, end user, and geography. Each segment offers unique insights into the market’s dynamics and growth potential.

By Product

The market is segmented into workstations/robotic platforms and reagents & consumables. Among these, the workstations/robotic platforms segment is expected to dominate the market in 2024. This segment's prominence is driven by the numerous advantages offered by automation in NGS library preparation, including:

• High efficiency
• Reduced turnaround time
• Lower per-sample costs
• Enhanced reproducibility compared to manual methods
• Growing adoption in pharmaceutical and biotechnology companies for drug discovery initiatives

Browse In Depth: https://www.meticulousresearch.com/product/north-america-ngs-automation-market-5736

By Sequencing Type

The sequencing type segment is categorized into whole genome sequencing, whole exome sequencing, targeted genome sequencing, and other sequencing types. Whole genome sequencing is projected to hold the largest market share in 2024. This dominance can be attributed to its widespread application in identifying novel drug targets and developing therapeutic techniques such as targeted therapies, gene therapies, and oligonucleotide therapies. These approaches play a pivotal role in advancing personalized medicine and precision therapies.

By Application

The market’s application segment includes drug discovery, clinical diagnostics (encompassing reproductive health diagnostics, oncology diagnostics, infectious disease diagnostics, and other clinical diagnostic applications), and other applications. Among these, the drug discovery segment is anticipated to account for the largest market share in 2024. This can be attributed to the increasing utilization of NGS in identifying novel drug targets and developing therapeutic solutions targeting specific genes and proteins. Such advancements are instrumental in revolutionizing treatment approaches for various diseases, including cancer and genetic disorders.

By End User

End users of NGS automation solutions include pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and other end users. In 2024, pharmaceutical and biotechnology companies are expected to dominate the market. Factors contributing to this segment’s significant share include:

• Rising R&D investments
• Growing demand for novel drug discovery initiatives utilizing advanced NGS technologies

By Geography

Among all the countries analyzed, the U.S. is expected to account for the largest share of the North America NGS automation market in 2024. This dominance is underpinned by several factors, including:

• Increasing R&D expenditure by pharmaceutical and biotechnology industries
• Presence of leading NGS automation platform providers in the region
• Favorable government initiatives supporting genomics research
• Growing adoption of NGS-based research applications
• Rising awareness of NGS-based diagnostic tests
• Increasing prevalence of cancer
• Favorable reimbursement scenarios supporting NGS adoption

Key Drivers of Market Growth

Increasing Cancer Prevalence

Cancer remains one of the leading causes of mortality in North America. The rising incidence of cancer cases necessitates advanced diagnostic and therapeutic solutions. NGS automation plays a critical role in enhancing the accuracy and efficiency of cancer diagnostics and treatment planning, driving its adoption in oncology research and clinical settings.

Rising Demand for NGS Automation in Laboratories

Laboratories across North America are increasingly adopting automation solutions to streamline workflows, enhance efficiency, and reduce manual errors. Automated NGS platforms significantly improve the reproducibility and throughput of genomic analyses, making them indispensable tools for modern laboratories.

Growing Pharmaceutical R&D Investments

The pharmaceutical industry’s commitment to innovation is reflected in its increasing investments in R&D. NGS automation solutions are integral to drug discovery and development processes, enabling researchers to identify novel targets and design personalized therapies more effectively.

Expanding Applications of NGS Technology

NGS technology’s versatility is evident in its wide-ranging applications, from clinical diagnostics to agricultural genomics. As researchers and clinicians continue to explore new uses for NGS, the demand for automated platforms that simplify complex workflows and improve outcomes is expected to grow.

Collaborations for Library Preparation Protocol Development

Collaborations among industry stakeholders are fostering the development of advanced library preparation protocols. These efforts aim to enhance the efficiency and accuracy of NGS workflows, further driving the adoption of automation solutions.

Challenges to Market Growth

Despite its promising growth trajectory, the North America NGS automation market faces certain challenges. The high cost of automation workstations remains a significant barrier, particularly for smaller laboratories and research institutions with limited budgets. Addressing this challenge will be crucial for ensuring the widespread adoption of NGS automation solutions.

Opportunities for Future Growth

The North America NGS automation market is poised for transformative growth, with several factors contributing to its bright future. These include:

• Technological Advancements : Continued innovation in NGS technologies and automation platforms will drive market expansion by offering more efficient, cost-effective, and user-friendly solutions.
• Increasing Focus on Personalized Medicine : The growing emphasis on tailored therapies and precision medicine will fuel the demand for NGS automation solutions that enable high-throughput genomic analyses.
• Emerging Applications in Non-Medical Fields : Beyond healthcare, NGS automation is finding applications in fields such as agriculture, environmental monitoring, and forensic science, presenting new avenues for market growth.

Quick Buy – North America NGS Automation Market – Opportunity Analysis and Industry Forecast (2024-2030), Research Report: https://www.meticulousresearch.com/Checkout/75503538

Conclusion

The North America NGS automation market is on an upward trajectory, driven by advancements in genomic technologies, increasing demand for streamlined workflows, and rising investments in R&D. As key players continue to innovate and address industry challenges, the market is expected to witness sustained growth, solidifying its role as a cornerstone of modern genomics research and clinical practice. With its transformative potential, NGS automation is set to revolutionize various industries, paving the way for a future of unprecedented scientific discovery and medical breakthroughs.

Contact Us:
Meticulous Research®
Email-  sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-  https://www.linkedin.com/company/meticulous-research